Stents having radiopaque mesh Patent Grant Zaver , et al. March 12, 2 [Carion; Brian S.]

Stents having radiopaque mesh

Zaver , et al. March 12, 2

Patent Grant 8394119

U.S. patent number 8,394,119 [Application Number 13/407,044] was granted by the patent office on 2013-03-12 for stents having radiopaque mesh. This patent grant is currently assigned to Covidien LP. The grantee listed for this patent is Brian S. Carion, Richard S. Kusleika, Steven G. Zaver. Invention is credited to Brian S. Carion, Richard S. Kusleika, Steven G. Zaver.

United States Patent	8,394,119
Zaver , et al.	March 12, 2013

Stents having radiopaque mesh

Abstract

A stent including a mesh made of strands. The mesh has at least one radiopaque strand and at least one non-radiopaque strand, and the at least one radiopaque strand and the at least one non-radiopaque strand each have different diameters. Each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I). The EI of all strands in the mesh is no more than five times the EI of the strand having the smallest EI of any of the strands.

Inventors:

Zaver; Steven G. (Plymouth, MN), Carion; Brian S. (White Bear Lake, MN), Kusleika; Richard S. (Eden Prairie, MN)

Applicant:

Name	City	State	Country	Type
Zaver; Steven G. Carion; Brian S. Kusleika; Richard S.	Plymouth White Bear Lake Eden Prairie	MN MN MN	US US US

Assignee:

Covidien LP (Mansfield, MA)

Family ID:

38229012

Appl. No.:

13/407,044

Filed:

February 28, 2012

Prior Publication Data


	Document Identifier	Publication Date
	US 20120158124 A1	Jun 21, 2012

Related U.S. Patent Documents


Application Number	Filing Date	Patent Number	Issue Date
11708651	Feb 20, 2007	8152833
60775818	Feb 22, 2006

Current U.S. Class:	606/200
Current CPC Class:	A61F 2/844 (20130101); A61F 2/0105 (20200501); A61F 2/90 (20130101); A61F 2/06 (20130101); A61F 2230/0067 (20130101); A61F 2002/018 (20130101); A61F 2250/0018 (20130101); A61F 2230/0006 (20130101); A61F 2002/016 (20130101); A61F 2250/0032 (20130101); A61F 2250/0098 (20130101); A61F 2310/00149 (20130101); A61F 2310/00071 (20130101); A61F 2310/00137 (20130101)
Current International Class:	A61M 29/00 (20060101)
Field of Search:	;606/108,194,200 ;623/1.11-1.13,1.15,1.2,1.34

References Cited [Referenced By]

U.S. Patent Documents


2919467	January 1960	Mercer
3278176	October 1966	Abolins
4321711	March 1982	Mano
4503569	March 1985	Dotter
4512338	April 1985	Balko et al.
4538622	September 1985	Samson et al.
4572186	February 1986	Gould et al.
4580568	April 1986	Gianturco
4655771	April 1987	Wallsten
4681110	July 1987	Wiktor
4733665	March 1988	Palmaz
4743251	May 1988	Barra
4768507	September 1988	Fischell et al.
4776337	October 1988	Palmaz
4856516	August 1989	Hillstead
4954126	September 1990	Wallsten
5011488	April 1991	Ginsburg
5035706	July 1991	Giantureo et al.
5041126	August 1991	Gianturco
5061275	October 1991	Wallsten et al.
5108416	April 1992	Ryan et al.
5160341	November 1992	Brenneman et al.
5180368	January 1993	Garrison
5192297	March 1993	Hull
5201757	April 1993	Heyn et al.
5209731	May 1993	Sterman et al.
5242399	September 1993	Lau et al.
5246420	September 1993	Kraus et al.
5246445	September 1993	Yachia et al.
5344426	September 1994	Lau et al.
5360443	November 1994	Barone et al.
5382259	January 1995	Phelps et al.
5401257	March 1995	Chevalier, Jr. et al.
5405380	April 1995	Gianotti et al.
5415637	May 1995	Khosravi
5421826	June 1995	Crocker et al.
5423849	June 1995	Engelson et al.
5449372	September 1995	Schmaltz et al.
5458615	October 1995	Klemm et al.
5476505	December 1995	Limon
5480423	January 1996	Ravenscroft et al.
5484444	January 1996	Braunschweiler et al.
5489295	February 1996	Piplani et al.
5507768	April 1996	Lau et al.
5522822	June 1996	Phelps et al.
5534007	July 1996	St. Germain et al.
5546880	August 1996	Ronyak et al.
5549662	August 1996	Fordenbacher
5562641	October 1996	Flomenblit et al.
5562728	October 1996	Lazarus et al.
5591225	January 1997	Okuda
5599291	February 1997	Balbierz et al.
5607466	March 1997	Imbert et al.
5609625	March 1997	Piplani et al.
5626602	May 1997	Gianotti et al.
5628783	May 1997	Quiachon et al.
5628788	May 1997	Pinchuk
5632771	May 1997	Boatman et al.
5632772	May 1997	Alcime et al.
5636641	June 1997	Fariabi
5639278	June 1997	Dereume et al.
D381932	August 1997	Walshe et al.
5667522	September 1997	Flomenblit et al.
5674276	October 1997	Andersen et al.
5683451	November 1997	Lenker et al.
5690120	November 1997	Jacobsen et al.
5690644	November 1997	Yurek et al.
5695499	December 1997	Helgerson et al.
5700269	December 1997	Pinchuk et al.
5702418	December 1997	Ravenscroft
5709702	January 1998	Cogita
5709703	January 1998	Lukic et al.
5718159	February 1998	Thompson
5725570	March 1998	Heath
5733327	March 1998	Igaki et al.
5735859	April 1998	Fischell et al.
5741325	April 1998	Chaikof et al.
5741333	April 1998	Frid
5749883	May 1998	Halpern
5749920	May 1998	Quiachon et al.
5769884	June 1998	Solovay
5769885	June 1998	Quiachon et al.
5776099	July 1998	Tremulis
5776142	July 1998	Gunderson
5782909	July 1998	Quiachon et al.
5797952	August 1998	Klein
5800518	September 1998	Piplani et al.
5810837	September 1998	Hofmann et al.
5817102	October 1998	Johnson et al.
5824039	October 1998	Piplani et al.
5824041	October 1998	Lenker et al.
5824042	October 1998	Lombardi et al.
5824044	October 1998	Quiachon et al.
5824058	October 1998	Ravenscroft et al.
5830229	November 1998	Konya et al.
5833632	November 1998	Jacobsen et al.
5836868	November 1998	Ressemann et al.
5868754	February 1999	Levine et al.
5876419	March 1999	Carpenter et al.
5888201	March 1999	Stinson et al.
5902266	May 1999	Leone et al.
5906640	May 1999	Penn et al.
5911717	June 1999	Jacobsen et al.
5916194	June 1999	Jacobsen et al.
5919204	July 1999	Lukic et al.
5928260	July 1999	Chin et al.
5944728	August 1999	Bates
5951599	September 1999	McCrory
5957973	September 1999	Quiachon et al.
5957974	September 1999	Thompson et al.
5964797	October 1999	Ho
5980530	November 1999	Willard et al.
5980533	November 1999	Holman
6012277	January 2000	Prins et al.
6014919	January 2000	Jacobsen et al.
6015432	January 2000	Rakos et al.
6017319	January 2000	Jacobsen et al.
6019778	February 2000	Wilson et al.
6019786	February 2000	Thompson
6022369	February 2000	Jacobsen et al.
6024754	February 2000	Engelson
6024763	February 2000	Lenker et al.
6027516	February 2000	Kolobow et al.
6033436	March 2000	Steinke et al.
6039758	March 2000	Quiachon et al.
6042589	March 2000	Marianne
6051021	April 2000	Frid
6056993	May 2000	Leidner et al.
6063111	May 2000	Hieshima et al.
6074407	June 2000	Levine et al.
6077295	June 2000	Limon et al.
6080191	June 2000	Summers
6093199	July 2000	Brown et al.
6096052	August 2000	Callister et al.
6102942	August 2000	Ahari
6123712	September 2000	Di Caprio et al.
6126685	October 2000	Lenker et al.
6132459	October 2000	Piplani et al.
6139543	October 2000	Esch et al.
6146415	November 2000	Fitz
6149680	November 2000	Shelso et al.
6159228	December 2000	Frid et al.
6165194	December 2000	Denardo
6165213	December 2000	Goicoechea et al.
6168592	January 2001	Kupiecki et al.
6174330	January 2001	Stinson
6183410	February 2001	Jacobsen et al.
6183508	February 2001	Stinson et al.
6197046	March 2001	Piplani et al.
6206868	March 2001	Parodi
6210400	April 2001	Hebert et al.
6210434	April 2001	Quiachon et al.
6210435	April 2001	Piplani et al.
6214038	April 2001	Piplani et al.
6214042	April 2001	Jacobsen et al.
6221102	April 2001	Baker et al.
6224609	May 2001	Ressemann et al.
6224829	May 2001	Piplani et al.
6231598	May 2001	Berry et al.
6235050	May 2001	Quiachon et al.
6241759	June 2001	Piplani et al.
6245087	June 2001	Addis
6245103	June 2001	Stinson
6251132	June 2001	Ravenscroft et al.
6260458	July 2001	Jacobsen et al.
6261305	July 2001	Marotta et al.
6261316	July 2001	Shaolian et al.
6270523	August 2001	Herweck et al.
6280465	August 2001	Cryer
6287331	September 2001	Heath
6290721	September 2001	Heath
6299636	October 2001	Schmitt et al.
6302810	October 2001	Yokota
6302893	October 2001	Limon et al.
6322576	November 2001	Wallace et al.
6322586	November 2001	Monroe et al.
6322587	November 2001	Quiachon et al.
6325826	December 2001	Vardi et al.
6334871	January 2002	Dor et al.
6336938	January 2002	Kavteladze et al.
6340367	January 2002	Stinson et al.
6340368	January 2002	Verbeck
6344041	February 2002	Kupiecki et al.
6348063	February 2002	Yassour et al.
6350199	February 2002	Williams et al.
6350278	February 2002	Lenker et al.
6355051	March 2002	Sisskind et al.
6355061	March 2002	Quiachon et al.
6364895	April 2002	Greenhalgh
6368344	April 2002	Fitz
6368557	April 2002	Piplani et al.
6375670	April 2002	Greenhalgh
6375676	April 2002	Cox
6379618	April 2002	Piplani et al.
6380457	April 2002	Yurek et al.
6389946	May 2002	Frid
6395017	May 2002	Dwyer et al.
6395022	May 2002	Piplani et al.
6398802	June 2002	Yee
6409683	June 2002	Fonseca et al.
6413235	July 2002	Parodi
6416519	July 2002	VanDusseldorp
6416536	July 2002	Yee
6419693	July 2002	Fariabi
6428489	August 2002	Jacobsen et al.
6440088	August 2002	Jacobsen et al.
6443971	September 2002	Boylan et al.
6443979	September 2002	Stalker et al.
6454999	September 2002	Farhangnia et al.
6468301	October 2002	Amplatz et al.
6478778	November 2002	Jacobsen et al.
6482221	November 2002	Hebert et al.
6491648	December 2002	Cornish et al.
6494895	December 2002	Addis
6497711	December 2002	Plaia et al.
6503450	January 2003	Afzal et al.
6514261	February 2003	Randall et al.
6514285	February 2003	Pinchasik
6524299	February 2003	Tran et al.
6527763	March 2003	Esch et al.
6533811	March 2003	Ryan et al.
6540778	April 2003	Quiachon et al.
6547779	April 2003	Levine et al.
6551352	April 2003	Clerc et al.
6572646	June 2003	Boylan et al.
6576006	June 2003	Limon et al.
6582460	June 2003	Cryer
6589273	July 2003	McDermott
6592616	July 2003	Stack et al.
6602271	August 2003	Adams et al.
6602280	August 2003	Chobotov
6605110	August 2003	Harrison
6613075	September 2003	Healy et al.
6622604	September 2003	Chouinard et al.
6623518	September 2003	Thompson et al.
6635068	October 2003	Dubrul et al.
6638243	October 2003	Kupiecki
6645240	November 2003	Yee
6646218	November 2003	Campbell et al.
6652508	November 2003	Griffin et al.
6656212	December 2003	Ravenscroft et al.
6656218	December 2003	Denardo et al.
6660024	December 2003	Flaherty et al.
6663666	December 2003	Quiachon et al.
6666881	December 2003	Richter et al.
6669719	December 2003	Wallace et al.
6673089	January 2004	Yassour et al.
6673100	January 2004	Diaz et al.
6679893	January 2004	Tran
6682557	January 2004	Quiachon et al.
6685735	February 2004	Ahari
6689120	February 2004	Gerdts
6689162	February 2004	Thompson
6699274	March 2004	Stinson
6709454	March 2004	Cox et al.
6712834	March 2004	Yassour et al.
6726700	April 2004	Levine
6733519	May 2004	Lashinski et al.
6740105	May 2004	Yodfat et al.
6740112	May 2004	Yodfat et al.
6743219	June 2004	Dwyer et al.
6755855	June 2004	Yurek et al.
6758885	July 2004	Leffel et al.
6767361	July 2004	Quiachon et al.
6773446	August 2004	Dwyer et al.
6793667	September 2004	Hebert et al.
6814746	November 2004	Thompson et al.
6814748	November 2004	Baker et al.
6818006	November 2004	Douk et al.
6833003	December 2004	Jones et al.
6849084	February 2005	Rabkin et al.
6858034	February 2005	Hijlkema et al.
6860893	March 2005	Wallace et al.
6860898	March 2005	Stack et al.
6860900	March 2005	Clerc et al.
6860901	March 2005	Baker et al.
6866677	March 2005	Douk et al.
6866680	March 2005	Yassour et al.
6887267	May 2005	Dworschak et al.
6890337	May 2005	Feeser et al.
6893451	May 2005	Cano et al.
6918921	July 2005	Brady et al.
6932837	August 2005	Amplatz et al.
6955685	October 2005	Escamilla et al.
6960227	November 2005	Jones et al.
6964670	November 2005	Shah et al.
6964672	November 2005	Brady et al.
6969396	November 2005	Krolik et al.
6976991	December 2005	Hebert et al.
6989024	January 2006	Hebert et al.
6994721	February 2006	Israel
7001422	February 2006	Escamilla et al.
7004964	February 2006	Thompson et al.
7011675	March 2006	Hemerick et al.
7037330	May 2006	Rivelli, Jr. et al.
7041129	May 2006	Rourke et al.
7066951	June 2006	Chobotov
7069835	July 2006	Nishri et al.
7074236	July 2006	Rabkin et al.
7093527	August 2006	Rapaport et al.
7101392	September 2006	Heath
7107105	September 2006	Bjorklund et al.
7118539	October 2006	Vrba et al.
7118594	October 2006	Quiachon et al.
7122050	October 2006	Randall et al.
7137990	November 2006	Hebert et al.
7166125	January 2007	Baker et al.
7169170	January 2007	Widenhouse
7169172	January 2007	Levine et al.
7172617	February 2007	Colgan et al.
7195639	March 2007	Quiachon et al.
7195648	March 2007	Jones et al.
7201768	April 2007	Diaz et al.
7201769	April 2007	Jones et al.
7211109	May 2007	Thompson
7213495	May 2007	McCullagh et al.
7220271	May 2007	Clubb et al.
7235096	June 2007	Van Tassel et al.
7264632	September 2007	Wright et al.
7275471	October 2007	Nishri et al.
7279005	October 2007	Stinson
7279208	October 2007	Goffena et al.
7294137	November 2007	Rivelli, Jr. et al.
7294146	November 2007	Chew et al.
7300456	November 2007	Andreas et al.
7300460	November 2007	Levine et al.
7306624	December 2007	Yodfat et al.
7309351	December 2007	Escamilla et al.
7311031	December 2007	McCullagh et al.
7320702	January 2008	Hammersmark et al.
7323001	January 2008	Clubb et al.
7331973	February 2008	Gesswein et al.
7331976	February 2008	McGuckin, Jr. et al.
7331985	February 2008	Thompson et al.
7338518	March 2008	Chobotov
7438712	October 2008	Chouinard
7462192	December 2008	Norton et al.
7468070	December 2008	Henry et al.
7470282	December 2008	Shelso
7473271	January 2009	Gunderson
7491224	February 2009	Cox et al.
7572290	August 2009	Yodfat et al.
7588597	September 2009	Frid
7763011	July 2010	Ortiz et al.
7771463	August 2010	Ton et al.
7942925	May 2011	Yodfat et al.
8007529	August 2011	Yan
2001/0044651	November 2001	Steinke et al.
2001/0049547	December 2001	Moore
2002/0004667	January 2002	Adams et al.
2002/0029061	March 2002	Amplatz et al.
2002/0035396	March 2002	Heath
2002/0062091	May 2002	Jacobsen et al.
2002/0078808	June 2002	Jacobsen et al.
2002/0082558	June 2002	Samson et al.
2002/0087119	July 2002	Parodi
2002/0111648	August 2002	Kusleika et al.
2002/0120323	August 2002	Thompson et al.
2002/0143361	October 2002	Douk et al.
2002/0169474	November 2002	Kusleika et al.
2002/0173839	November 2002	Leopold et al.
2002/0188314	December 2002	Anderson et al.
2003/0023299	January 2003	Amplatz et al.
2003/0069522	April 2003	Jacobsen et al.
2003/0100945	May 2003	Yodfat et al.
2003/0130684	July 2003	Brady et al.
2003/0135258	July 2003	Andreas et al.
2003/0163155	August 2003	Haverkost et al.
2003/0163156	August 2003	Hebert et al.
2003/0176884	September 2003	Berrada et al.
2003/0187495	October 2003	Cully et al.
2003/0212429	November 2003	Keegan et al.
2003/0212430	November 2003	Bose et al.
2004/0024416	February 2004	Yodfat et al.
2004/0030265	February 2004	Murayama et al.
2004/0044395	March 2004	Nelson
2004/0073300	April 2004	Chouinard et al.
2004/0088037	May 2004	Nachreiner et al.
2004/0093010	May 2004	Gesswein et al.
2004/0153117	August 2004	Clubb et al.
2004/0162606	August 2004	Thompson
2004/0172055	September 2004	Huter et al.
2004/0193178	September 2004	Nikolchev
2004/0193179	September 2004	Nikolchev
2004/0193208	September 2004	Talpade et al.
2004/0199243	October 2004	Yodfat
2004/0215332	October 2004	Frid
2004/0220585	November 2004	Nikolchev
2004/0220608	November 2004	D'Aquanni et al.
2004/0220663	November 2004	Rivelli
2004/0254628	December 2004	Nazzaro et al.
2004/0260331	December 2004	D'Aquanni et al.
2005/0004595	January 2005	Boyle et al.
2005/0021075	January 2005	Bonnette et al.
2005/0038447	February 2005	Huffmaster
2005/0055047	March 2005	Greenhalgh
2005/0090888	April 2005	Hines et al.
2005/0101989	May 2005	Cully et al.
2005/0137680	June 2005	Ortiz et al.
2005/0149111	July 2005	Kanazawa et al.
2005/0165441	July 2005	McGuckin et al.
2005/0177186	August 2005	Cully et al.
2005/0192620	September 2005	Cully et al.
2005/0209672	September 2005	George et al.
2005/0209678	September 2005	Henkes et al.
2005/0246010	November 2005	Alexander et al.
2005/0267568	December 2005	Berez et al.
2005/0283220	December 2005	Gobran et al.
2005/0288764	December 2005	Snow et al.
2005/0288766	December 2005	Plain et al.
2006/0020324	January 2006	Schmid et al.
2006/0036309	February 2006	Hebert et al.
2006/0089703	April 2006	Escamilla et al.
2006/0095213	May 2006	Escamilla et al.
2006/0111771	May 2006	Ton et al.
2006/0116750	June 2006	Hebert et al.
2006/0184238	August 2006	Kaufmann et al.
2006/0195118	August 2006	Richardson
2006/0206148	September 2006	Khairkhahan et al.
2006/0206200	September 2006	Garcia et al.
2006/0206201	September 2006	Garcia et al.
2006/0212127	September 2006	Karabey et al.
2006/0271149	November 2006	Berez et al.
2006/0271153	November 2006	Garcia et al.
2007/0021816	January 2007	Rudin
2007/0043419	February 2007	Nikolchev et al.
2007/0060994	March 2007	Gobran et al.
2007/0073379	March 2007	Chang
2007/0077347	April 2007	Richter
2007/0100414	May 2007	Licata et al.
2007/0112415	May 2007	Bartlett
2007/0119295	May 2007	McCullagh et al.
2007/0123969	May 2007	Gianotti
2007/0162104	July 2007	Frid
2007/0167980	July 2007	Figulla et al.
2007/0198076	August 2007	Hebert et al.
2007/0203559	August 2007	Freudenthal et al.
2007/0203563	August 2007	Hebert et al.
2007/0208367	September 2007	Fiorella et al.
2007/0208376	September 2007	Meng
2007/0225760	September 2007	Moszner et al.
2007/0233175	October 2007	Zaver et al.
2007/0255386	November 2007	Tenne
2007/0280850	December 2007	Carlson
2007/0299500	December 2007	Hebert et al.
2007/0299501	December 2007	Hebert et al.
2007/0299502	December 2007	Hebert et al.
2008/0033341	February 2008	Grad
2008/0039930	February 2008	Jones et al.
2008/0039933	February 2008	Yodfat et al.
2008/0082154	April 2008	Tseng et al.
2008/0114391	May 2008	Dieck et al.
2008/0125855	May 2008	Henkes et al.
2008/0208320	August 2008	Tan-Malecki et al.
2008/0221666	September 2008	Licata et al.
2008/0221670	September 2008	Clerc et al.
2008/0221671	September 2008	Chouinard et al.
2008/0255654	October 2008	Hebert et al.
2008/0255655	October 2008	Kusleika et al.
2008/0262590	October 2008	Murray
2008/0269774	October 2008	Garcia et al.
2008/0275497	November 2008	Palmer et al.
2008/0275498	November 2008	Palmer et al.
2008/0294104	November 2008	Mawad
2008/0300667	December 2008	Hebert et al.
2009/0024202	January 2009	Dave et al.
2009/0024205	January 2009	Hebert et al.
2009/0030496	January 2009	Kaufmann et al.
2009/0030497	January 2009	Metcalf et al.
2009/0054981	February 2009	Frid et al.
2009/0099643	April 2009	Hyodoh et al.
2009/0105802	April 2009	Henry et al.
2009/0105803	April 2009	Shelso
2009/0125093	May 2009	Hansen
2009/0192536	July 2009	Berez et al.
2009/0192587	July 2009	Frid
2009/0198318	August 2009	Berez et al.
2009/0270974	October 2009	Berez et al.
2009/0287241	November 2009	Berez et al.
2009/0287288	November 2009	Berez et al.
2009/0288000	November 2009	McPherson
2009/0292348	November 2009	Berez et al.
2009/0318947	December 2009	Garcia et al.
2009/0319017	December 2009	Berez et al.
2010/0010624	January 2010	Berez et al.
2010/0174269	July 2010	Tompkins et al.
2010/0174309	July 2010	Fulkerson et al.
2010/0179583	July 2010	Carpenter et al.
2010/0179647	July 2010	Carpenter et al.
2010/0198334	August 2010	Yodfat et al.
2010/0318178	December 2010	Rapaport et al.
2011/0016427	January 2011	Douen
2011/0166592	July 2011	Garcia et al.
2011/0179389	July 2011	Douen
2011/0190862	August 2011	Bashiri et al.
2011/0245862	October 2011	Dieck et al.

Foreign Patent Documents


101472537	Jul 2009	CN
1485043	Jul 2008	EP
1942972	Jul 2008	EP
1872742	May 2009	EP
1455679	Jul 2009	EP
2556210	Apr 1988	FR
10-328216	Dec 1998	JP
11-506686	Jun 1999	JP
11-299901	Nov 1999	JP
2001-509412	Jul 2001	JP
2003-520103	Jul 2003	JP
2005-074230	Mar 2005	JP
2006-506201	Feb 2006	JP
2008-541832	Nov 2008	JP
4673987	Apr 2011	JP
WO-88/00813	Feb 1988	WO
WO-95/09586	Apr 1995	WO
WO-98/04211	Feb 1998	WO
WO-99/02092	Jan 1999	WO
WO-99/49812	Dec 1999	WO
WO-01/05331	Jan 2001	WO
WO-0152771	Jul 2001	WO
WO-02/05729	Jun 2002	WO
WO-02/47579	Jun 2002	WO
WO 02/054988	Jul 2002	WO
WO-03/007840	Jan 2003	WO
WO-03/049600	Oct 2003	WO
WO-2004/087006	Oct 2004	WO
WO-2005/023149	Dec 2005	WO
WO 2005/115118	Dec 2005	WO
WO-2006/127005	Nov 2006	WO
WO-2007/139689	Sep 2008	WO
WO-2007/139699	Sep 2008	WO
WO-2005/115118	Jul 2009	WO
WO-2009/105710	Aug 2009	WO

Other References

Benndorf, et al. Treatment of a Ruptured Dissecting Vertebral Artery Aneurysm with Double Stent Placement: Case Report AJNR Am J Neuroradiol, Nov.-Dec. 2001, vol. 22, pp. 1844-1848. cited by applicant .
Brilstra, et al., Treatment of Intracranial Aneurysms by Embolization with Coils: A Systematic Review, Stroke, Journal of the American Heart Association, 1999, vol. 30, pp. 470-476. cited by applicant .
Ferguson, Gary, Physical Factors in the Initiation, Growth and Rupture of Human Intracranial Saccular Ameurysms, J. Neurosurg, Dec. 1972, vol. 37, pp. 666-667. cited by applicant .
Geremia, et al., Embolization of Experimentally Created Aneurysms with Intravascular Stent Devices, ANJR American Journal of Neuroradiology, Aug. 1994, vol. 15, pp. 1223-1231. cited by applicant .
Geremia, et al., Occlusion of Experimentally Created Fusiform Aneurysms with Porous Metallic Stents, ANJR Am J Neuroradiol, Apr. 2000, Issue 21, pp. 739-745. cited by applicant .
Lanzino, et al., Efficacy and Current Limitations of Intravascular Stents for Intracranial Internal Carotid, Vertebral, and Basilar Artery Aneurysms, Journal of Neurosurgery, Oct. 1999, vol. 91, Issue 4, pp. 538-546. cited by applicant .
Lieber, et al., Alteration of Hemodynamics in Aneurysm Models by Stenting: Influence of Stent Porosity, Ann of Biomedical Eng., 1997, vol. 25, pp. 460-469, Buffalo, NY. cited by applicant .
Lieber, et al., The Physics of Endoluminal Stenting in the Treatment of Cerebrovascular Aneurysms, Neurological Research, 2002, Vcol 24, Issue Supplement 1, pp. S32-S42. cited by applicant .
Moss, et al., Vascular Occlusion with a Balloon-Expadable Stent Occluder, Radiology, May 1994, vol. 191, Issue 2, pp. 483-486. cited by applicant .
Pereira, Edgard, History of Endovascular Aneurysm Occlusion, Management of Cerebral Aneurysms, 2004, pp. 11-26. cited by applicant .
Qureshi, Adnan, Endovascular Treatment of Cerebrovascular Diseases and Intracranial Neoplasms, The Lancelet, Mar. 2004, vol. 363, pp. 804-813. cited by applicant .
Steiger, Pathophysiology of Development and Rupture of Cerebral Aneurysms, Acta Nurochirurgica, Mar. 1990, vol. Supplementum 48, Pages in 62 pages. cited by applicant .
Tenaglia, et al., Ultrasound Guide Wire-Directed Stent Deployment, Duke University Medical Center, Department of Medicine, 1993 USA. cited by applicant .
Yu, et al., A Steady Flow Analysis on the Stented and Non-Stented Sidewall Aneurysm Models, Medical Engineering and Physics, Apr. 1999, Issue 21, pp. 133-141. cited by applicant .
Jul. 30, 2007 Search Report and Written Opinion for Counterpart International Application No. PCT/US2007/004406 (14 pages). cited by applicant.

Primary Examiner: Severson; Ryan
Assistant Examiner: Cronin; Ashley
Attorney, Agent or Firm: Kertz, Esq.; Mark J.

Parent Case Text

This application is a continuation of U.S. application Ser. No. 11/708,651, filed Feb. 20, 2007, which claims the benefit of U.S. Provisional Application No. 60/775,818, filed Feb. 22, 2006, entitled "Embolic Protection System Having Radiopaque Filter Mesh," the contents of each of which are hereby incorporated by reference herein.

Claims

What is claimed is:

1. A stent comprising a mesh, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, the at least one radiopaque strand and the at least one non-radiopaque strand each having different cross-sectional dimensions, and wherein each of the strands has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the EI of each of the strands is no more than five times the EI of a strand having the smallest EI of any of the strands.

2. The stent of claim 1, wherein the mesh is self-expanding.

3. The stent of claim 1, wherein the mesh is self-contracting.

4. The stent of claim 1, wherein the mesh is tubular.

5. The stent of claim 4, wherein the mesh is braided.

6. The stent of claim 1, wherein each strand has a round cross-section.

7. The stent of claim 6, wherein the mesh comprises only two types of strands, a first type being a radiopaque strand and having a cross-sectional dimension D1 and a second type being a non-radiopaque strand and having a cross-sectional dimension D2.

8. The stent of claim 7, wherein both the first and second types of strands are monofilaments.

9. The stent of claim 1, wherein the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 10 percent or more.

10. The stent of claim 1, wherein the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 20 percent or more.

11. The stent of claim 1, wherein the mesh comprises more radiopaque strands than non-radiopaque strands.

12. The stent of claim 1, wherein the mesh comprises more non-radiopaque strands than radiopaque strands.

13. The stent of claim 1, wherein the EI of each of the strands is no more than four times the EI of a strand having the smallest EI of any of the strands.

14. The stent of claim 1, wherein the EI of each of the strands is no more than two times the EI of a strand having the smallest EI of any of the strands.

15. The stent of claim 14, wherein the largest cross-sectional dimension of a strand is no more than two times the smallest cross-sectional dimension of any other strand.

16. The stent of claim 1, wherein the EI of each of the strands is no more than 1.5 times the EI of a strand having the smallest EI of any of the strands.

17. The stent of claim 1, wherein the EI of each of the strands is no more than 1.3 times the EI of a strand having the smallest EI of any of the strands.

18. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than five times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

19. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than four times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

20. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than three times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

21. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than two times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

22. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than 1.5 times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

23. The stent of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

24. The stent of claim 1, wherein the mesh comprises at least two types of strands, each strand having a round cross-section, a first type of strand being a radiopaque strand and having a cross-sectional dimension D1 and a second type of strand being a non-radiopaque strand and having a cross-sectional dimension D2, cross-sectional dimension D1 being larger than cross-sectional dimension D2, wherein the mesh comprises pores and when the mesh is at rest in free space no pore adjacent to a strand having a cross-sectional dimension D1 has an area more than five times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

25. The stent of claim 1, wherein the mesh comprises at least two types of strands, each strand having a round cross-section, a first type of strand being a radiopaque strand and having a cross-sectional dimension D1 and a second type of strand being a non-radiopaque strand and having a cross-sectional dimension D2, cross-sectional dimension D1 being larger than cross-sectional dimension D2, wherein the mesh comprises pores and when the mesh is at rest in free space no pore adjacent to a strand having a cross-sectional dimension D1 has an area more than two times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.

26. The stent of claim 1, wherein the at least one radiopaque strand is made of homogeneous metal or metal alloy.

27. The stent of claim 26, wherein the at least one radiopaque strand is selected from the group consisting of strands made of gold, platinum, tungsten, tantalum, and alloys thereof.

28. The stent of claim 1, wherein the at least one non-radiopaque strand is made of metal.

29. The stent of claim 28, wherein the at least one non-radiopaque strand is selected from the group consisting of strands made of stainless steel and nitinol.

30. The stent of claim 28, wherein the at least one non-radiopaque strand is superelastic.

31. The stent of claim 1, wherein the largest cross-sectional dimension of a strand is no more than five times the smallest cross-sectional dimension of any other strand.

32. The stent of claim 1, wherein the largest cross-sectional dimension of a strand is no more than four times the smallest cross-sectional dimension of any other strand.

33. The stent of claim 1, wherein the largest cross-sectional dimension of a strand is no more than two times the smallest cross-sectional dimension of any other strand.

34. The stent of claim 1, wherein the largest cross-sectional dimension of a strand is no more than 1.5 times the smallest cross-sectional dimension of any other strand.

35. The stent of claim 1, wherein the at least one radiopaque strand is a monofilament.

36. The stent of claim 1, wherein the at least one non-radiopaque strand is a monofilament.

37. The stent of claim 1, wherein the at least one radiopaque strand is a multifilament wire.

38. The stent of claim 1, wherein at least one strand is a monofilament wire from which some material has been removed in the form of slots.

39. The stent of claim 1, wherein the at least one non-radiopaque strand is made of nitinol.

40. The stent of claim 1, wherein the cross-sectional dimensions are diameters.

41. The stent of claim 1, wherein the mesh is at least partially occlusive to flow of fluid or particles therethrough.

42. A method of deploying a stent in a lumen defined by the walls of a vessel in a patient's body comprising: providing the stent, the stent comprising a mesh, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, the at least one radiopaque strand and the at least one non-radiopaque strand each having different cross-sectional dimensions, and wherein each of the strands has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the EI of each of the strands is no more than five times the EI of a strand having the smallest EI of any of the strands; delivering the stent percutaneously to a region of interest in the lumen of the patient's body; and using fluoroscopy to visualize the stent in the lumen of the patient's body.

43. The method of claim 42, wherein the mesh is self-expanding.

44. The method of claim 42, wherein the mesh is self-contracting.

45. The method of claim 42, wherein the at least one radiopaque strand is made of homogeneous metal or metal alloy.

46. The method of claim 42, whereby the mesh at least partially occludes flow of fluid or particles therethrough.

Description

FIELD OF THE INVENTION

The present invention relates to embolic protection systems, and, more particularly, to embolic protection systems for use in blood vessels.

BACKGROUND OF THE INVENTION

Vessels are commonly treated to reduce or eliminate narrowings caused by arteriosclerotic disease. Interventional treatments can include use of balloon angioplasty, stenting, thrombectomy, atherectomy, and other procedures. During treatment particulate debris can be generated at the treatment site. Infarcts, strokes, and other major or minor adverse events are caused when debris embolizes into vasculature distal to the treatment site.

To prevent embolization of debris, embolic protection devices have been developed. During a procedure such devices can be placed distal or proximal to the treatment site. Embolic protection devices can remove emboli from the bloodstream by filtering debris from blood, by occluding blood flow followed by aspiration of debris, or can cause blood flow reversal to effect removal of debris. The shape, length and other characteristics of an embolic protection device are typically chosen based on the anatomical characteristics in the vicinity of the treatment site. However, some anatomies present specific challenges due to the anatomical shape or configuration.

Difficulties can arise where embolic protection devices are not properly deployed within the anatomy. For example, if a device does not properly engage a lumenal wall, leaving a gap, then particulate matter entrained in a fluid in the lumen can bypass the protection device. It would be an advantage to be able to visualize whether or not there are gaps between the embolic protection device and the lumenal wall. Also, when a protection device is being advanced or withdrawn from a lumen it may engage with an obstruction. The obstruction may be a stent that has been placed in a blood vessel, an area of plaque build-up, lumen tortuosity, or other structure. The operator of the embolic protection device may need to employ different techniques to advance or withdraw the device depending on the cause of engagement. Thus, it would be advantageous for the operator to be able to visualize the exact location of the device in the lumen.

Difficulties can also arise when recovering an embolic protection device. One problem that can occur is that the embolic protection device may require excessive force during recovery, for example when drawing the device into a recovery catheter. The causes of such excessive force can vary. For example the device could be filled with embolic debris and thereby not fit into the lumen of a recovery catheter, the device may be caught on a structure such as a stent or a catheter tip, or other causes. It would be advantageous to the operator to visualize the embolic protection device so that appropriate actions can be taken so as to successfully recover the device. Further discussion of these issues is provided in U.S. Patent Publication No. 2002/0188314 A1, by Anderson et. al., entitled "Radiopaque Distal Embolic Protection Device", the contents of which are incorporated herein by reference.

The current art employs a variety of approaches to solve the problem of visualizing an embolic protection device in a patient. All of the current approaches have limitations. For example, some devices have radiopaque coatings; however coatings may become separated from the underlying substrate. Radiopaque filler materials have been employed in polymer film devices; however the fillers detract from the mechanical properties of the films and the filler/film composites, being thin, are not very visible. Strands of drawn filled tubing (DFT) have been used and have good mechanical and radiopacity characteristics; however DFT is expensive. Individual strands of radiopaque wire, such as platinum, gold, tungsten, and their alloys have good radiopacity but can have unsuitable strength or elastic yield limits, and when comprising a portion of the wires in a woven structure such as a braid, can alter the braid wire spacing in the vicinity of the strand of radiopaque wire due to differing mechanical properties compared to neighboring non-radiopaque wires. For some filter devices, uniform wire spacing is desired and altered braid wire spacing can cause unacceptably large pores in the braid.

Accordingly, a need exists for an embolic protection device having improved radiopacity that is inexpensive, durable, provides visibility to the appropriate regions of the device, and which uses technology that does not compromise the performance of the device.

SUMMARY OF THE INVENTION

According to one aspect of the present invention, an embolic protection device comprises a woven mesh comprising radiopaque and non-radiopaque wires. The mechanical properties of the radiopaque wires are selected to match the mechanical properties of the non-radiopaque wires. The non-radiopaque wires can be superelastic. The radiopaque wires are woven into pre-programmed locations so that after processing the woven mesh into a device the radiopaque wires will concentrate at a preferred location within the device. A method is provided in which the device operator visualizes the radiopaque wires so as to guide how the device is utilized in a patient.

The invention provides a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body, comprising: a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.

The invention provides a method of deploying a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body comprising: providing the device for filtering emboli, the device comprising a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand; delivering the device percutaneously to a region of interest in the lumen of the patient's body; and using fluoroscopy to visualize the filter element in the lumen of the patient's body.

The invention provides a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.

It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.

BRIEF DESCRIPTION OF THE DRAWINGS

The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying drawings.

FIGS. 1A to 1C illustrate conceptually a partial plan view of braided tubular mesh having radiopaque and non-radiopaque wires in accordance with the present invention.

FIG. 2 illustrates conceptually a side view of a filter formed from braided tubular mesh in accordance with the present invention.

FIG. 3 illustrates conceptually a method for forming a filter from braided tubular mesh in accordance with the present invention.

FIGS. 4A and 4B illustrate conceptually plan views of braided mesh in accordance with the present invention.

FIGS. 5A to 5E illustrate cross sectional or side views of wires in accordance with the present invention.

DETAILED DESCRIPTION OF THE INVENTION

The invention provides a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body, comprising: a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.

In one embodiment, the device further comprises an elongate support member and the filter element is carried on a portion of the elongate support member. In another embodiment, the filter element has proximal and distal portions and a central portion, the filter element having a shape in the expanded configuration which defines a cavity having a proximal facing opening. In one embodiment, the filter element has a proximal facing opening portion and this portion is radiopaque.

The filter element may be self-expanding or self-contracting. The mesh may be tubular and/or braided. In one embodiment, each strand has a round cross-section. In another embodiment, the mesh comprises only two types of strands, a first type being a radiopaque strand and having a diameter D1 and a second type being a non-radiopaque strand and having a diameter D2. In one embodiment, the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 10 percent or more. In another embodiment, the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 20 percent or more.

In one embodiment, the mesh comprises more radiopaque strands than non-radiopaque strands. In another embodiment, the mesh comprises more non-radiopaque strands than radiopaque strands. In embodiments of the invention, the largest EI of a strand is no more than four times the smallest EI of a strand, the largest EI of a strand is no more than two times the smallest EI of a strand, the largest EI of a strand is no more than 1.5 times the smallest EI of a strand, or the largest EI of a strand is no more than 1.3 times the smallest EI of a strand.

In embodiments of the invention, the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than five times the mesh pore size, when the mesh is at rest in free space no pore has an area more than four times the mesh pore size, when the mesh is at rest in free space no pore has an area more than three times the mesh pore size, when the mesh is at rest in free space no pore has an area more than two times the mesh pore size, when the mesh is at rest in free space no pore has an area more than 1.5 times the mesh pore size, or when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size. The mesh pore size is the average area of five pores serially adjacent to the pore.

In embodiments of the invention, the mesh comprises at least two types of strands, each strand having a round cross-section, a first type of strand being a radiopaque strand and having a diameter D1 and a second type of strand being a non-radiopaque strand and having a diameter D2, diameter D1 being larger than diameter D2, wherein the mesh comprises pores and when the mesh is at rest in free space no pore adjacent to a strand having a diameter D1 has an area more than five times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore. In other related embodiments, when the mesh is at rest in free space no pore adjacent to a strand having a diameter D1 has an area more than four times the mesh pore size, more than three times the mesh pore size, more than two times the mesh pore size, more than 1.5 times the mesh pore size, or more than 1.2 times the mesh pore size.

In one embodiment, the at least one radiopaque strand is made of homogeneous metal or metal alloy. In another embodiment, the at least one radiopaque strand is selected from the group consisting of strands made of gold, platinum, tungsten, tantalum, and alloys thereof. Other radiopaque substances may be used. In an embodiment, the at least one non-radiopaque strand is made of metal. In one embodiment, the at least one non-radiopaque strand is selected from the group consisting of strands made of stainless steel and nitinol. Other non-radiopaque substances may be used. In one embodiment, the at least one non-radiopaque strand is superelastic.

In embodiments of the invention, the largest diameter of a strand is no more than five times the smallest diameter of a strand, the largest diameter of a strand is no more than four times the smallest diameter of a strand, the largest diameter of a strand is no more than two times the smallest diameter of a strand, or the largest diameter of a strand is no more than 1.5 times the smallest diameter of a strand. In one embodiment, the largest diameter of a strand is no more than two times the smallest diameter of a strand, and the largest EI of a strand is no more than two times the smallest EI of a strand.

In one embodiment, the at least one radiopaque strand is a monofilament. In one embodiment, the at least one non-radiopaque strand is a monofilament. In another embodiment, the mesh comprises only two types of strands, a first type being a radiopaque strand and having a diameter D1 and a second type being a non-radiopaque strand and having a diameter D2, and both the first and second types of strands are monofilaments. In one embodiment, the at least one radiopaque strand is a multifilament wire. In another embodiment, at least one strand is a monofilament wire from which some material has been removed in the form of slots. In one embodiment, the at least one non-radiopaque strand is made of nitinol.

The invention provides a method of deploying a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body comprising: providing the device for filtering emboli, the device comprising a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand; delivering the device percutaneously to a region of interest in the lumen of the patient's body; and using fluoroscopy to visualize the filter element in the lumen of the patient's body. The device used in this method can be any of the embodiments described herein. In one embodiment, the filter element has proximal and distal portions and a central portion, the filter element having a shape in the expanded configuration which defines a cavity having a proximal facing opening, the filter element has a proximal facing opening portion and this portion is radiopaque, and the proximal facing opening portion of the filter element is visualized to confirm that this portion is adequately deployed against the walls of the vessel.

The invention provides a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand. The mesh can be any of the embodiments described herein in connection with the mesh that is part of the device for filtering emboli.

In the discussion below the invention is described using as examples filters comprised of braided metal strands. It is to be understood that the invention is not limited to the examples below. For example, the mesh of the invention can be comprised of strands that are woven, non-woven, or knitted to form the mesh. The mesh can have uniform strand spacing so as to define a structure with relatively uniformly sized openings between strands or can have variable strand spacing so as to define a structure with varied size openings between strands. The mesh can be coated with an elastic polymer film in whole or in part, or with another material, so as to reduce in size or eliminate the openings between strands. The coated mesh may be partially or totally occlusive to flow of fluid or particles therethrough. In some embodiments the metal strands may be superelastic alloys comprised of radiopaque alloy constituents. In some preferred embodiments a metal strand is comprised of nickel-titanium-platinum or nickel-titanium-tantalum alloy. In addition, some or all of the strands may be comprised of materials other than metal including but not limited to engineering polymers such as PEEK (polyetheretherketone), liquid crystal, polyamide, or polyester; ceramics; glass-ceramics; metallic glasses; or other materials known in the art. In some embodiments the aforementioned materials can be comprised of radiopaque filler materials. In some embodiments the strands are homogeneous in the sense that they are not comprised of separate layers. It is further understood that the cross section of some or all of the strands can be round, ovoid, square, rectangular, triangular, irregular, symmetrical, non-symmetrical, or other shapes.

FIGS. 1A to 1C illustrate conceptually partial plan views of braided meshes having radiopaque and non-radiopaque wires in accordance with the present invention. For clarity only the braided wires along half of the braided perimeter of the tube are shown. Braided wires arranged below the illustrated wires are not shown. Also for clarity the radiopaque wires in FIGS. 1A to 1C are shown as having slightly increased diameter as compared to non-radiopaque wires, although it is understood that the relative sizes of the radiopaque and non-radiopaque filaments may not be as illustrated and generally will be determined according to the teachings below. Further, strands are generally illustrated as intersecting at angles of approximately 90.degree., although it is understood that within the scope of the invention strands can intersect or overlap at any angle.

In FIG. 1A braided tubular mesh 10 is comprised of interwoven wires 12 and 14. Non-radiopaque wires 12 comprise the majority of the wires and two sets of adjacent pairs of radiopaque wires 14 are interwoven with the non-radiopaque wires 12. Braided tubular mesh 10 has a number of pores 16 defined by the wires, and each pore has a size, the pore size defined as the area bounded by the wires forming the perimeter of the pore. Braided tubular mesh 10 can be formed of a variety of materials. Metal wires are preferred, and superelastic nitinol is particularly preferred for the non-radiopaque wires 12. Braided tubular mesh 10 has a diameter D, which is the diameter of the braided tubular mesh at rest in free space. Diameter D is determined by braiding processing parameters and wire diameters used. Heat treatments may be used to help stabilize diameter D, especially when wire materials such as nitinol are used. A braid comprised of nitinol wire is typically heat set at 400 to 600.degree. C. for 1 to 60 minutes to stabilize the braid diameter. In a preferred embodiment nitinol wire is heat set at 425.degree. C. for 20 minutes to stabilize the braid diameter. Non-nitinol wires may be annealed at temperatures that will stress relieve or even recrystallize the materials in order to stabilize the tubular braid diameter. It is understood that self-expanding or self-contracting devices can be comprised of braided tubular mesh 10. Self-expanding devices are devices in which, during use, braided tubular mesh 10 is compressed and subsequently allowed to expand without application of forces external to the mesh for causing expansion. Self-contracting devices are devices in which, during use, braided tubular mesh 10 is expanded and subsequently allowed to contract without application of forces external to the mesh for causing contraction. It is advantageous to construct self-expanding or self-contracting devices at least in part from wires that have elastic strain limits higher than the elastic strains generated in the wires during use of these devices, and to process the wires so as to retain or enhance the elastic strain limits of the wires chosen. Devices which are neither self-expanding nor self-contracting may also be comprised of braided tubular mesh 10. Devices of the invention may also be comprised of braided tubular mesh or strands which deform upon expansion or contraction. The strands of such devices may be processed or chosen such that the elastic strain limit of the strands are less than the elastic strains generated in the strand during use of the device.

FIG. 1B illustrates braided tubular mesh 10 comprised of a single radiopaque wire 14 interwoven with non-radiopaque wires 12 and FIG. 1C illustrates braided tubular mesh 10 comprised primarily of radiopaque wires 14 interwoven with a minority of non-radiopaque wires 12. It is understood that multiple combinations of interwoven radiopaque and non-radiopaque wires 14 and 12 are possible within the scope of the invention, and that the number, proportion, and positioning of radiopaque and non-radiopaque wires within the mesh will be chosen based on the desired device functional and other requirements.

FIG. 2 illustrates conceptually a side view of filter 20 formed from a braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 in accordance with the present invention. For clarity the wires on the back side of the filter are not shown. Filters similar to that shown in FIG. 2 can be made by enlarging a pore in the side wall of the braid using a tapered mandrel and stabilized in the desired shape by heat treating on a mandrel. Processing details for making a filter using these methods are disclosed in U.S. Pat. No. 6,325,815 B1 to Kusleika et al., entitled "Temporary Vascular Filter", the contents of which are incorporated herein by reference. In filter 20, radiopaque wires 14 are bunched at the opening of the filter, providing improved visibility under fluoroscopy of the perimeter 26 of mouth 24 of the filter. In an alternate embodiment radiopaque wires 14 are bunched distal to mouth 24 of the filter, providing improved visibility under fluoroscopy of the portion of the filter apposing a vessel wall during use. Radiopaque wires 14 also extend throughout the body 22 of the filter mesh, providing visibility under fluoroscopy to the body of the filter.

FIG. 3 illustrates conceptually a method for forming filter 20 from braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 in accordance with the present invention. Pore 35 is chosen as the pore to enlarge into mouth 24 of filter 20. Pore 35 is chosen specifically such that radiopaque wires 14a will be bunched along the perimeter 26 of filter mouth 24 during the filter forming process. In FIG. 3, pore 35 is located 3 pores from the intersecting pore 38 of radiopaque filaments 14a. In one example, braided tubular mesh 10 is comprised of 36 wires and has a diameter D of 3 mm before forming into filter 20. Two pairs of radiopaque wires 14a are interwoven into tubular mesh 10 as illustrated in FIG. 3, and the remaining 32 wires are non-radiopaque nitinol. Pore 35 is located 8 pores from intersecting pore 38 of radiopaque filaments 14a. In another example, braided tubular mesh 10 is comprised of 72 wires and has a diameter D of 7 mm before forming into filter 20. Two pairs of radiopaque wires 14a are interwoven into tubular mesh 10 as illustrated in FIG. 3, and the remaining 68 wires are non-radiopaque. Pore 35 is located 15 pores from intersecting pore 38 of radiopaque filaments 14a. It is understood that the location chosen for piercing braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 will vary within the scope of the invention and will depend on the application contemplated and results desired.

When adding radiopaque wires to a mesh comprised primarily of non-radiopaque wires it is often desired to increase the diameter of the radiopaque wire relative to the diameter of the non-radiopaque wire so as to increase the visibility of the radiopaque wire under fluoroscopy. FIG. 4A illustrates the effect of adding a larger wire 42 to a mesh 40, wherein the pore sizes 45 adjacent to the larger wires are increased in area as compared to pore sizes 47 in the portion of the mesh comprised of smaller wires 44 due to the presence of the larger wire 42 relative to the adjacent smaller wires 44 in the mesh. For certain applications, including some filter devices, large pores in the braid can be unacceptable because the large pores will allow large emboli to pass through the filter.

FIG. 4B illustrates braided tubular mesh 40 comprised of a large wire 42 and multiple smaller wires 44 having uniformly sized pores 48, a configuration preferred for filtering applications such as for distal embolic protection devices. The uniformly sized pores illustrated in FIG. 4B are achieved by using similar stiffness wires in the mesh. A useful index of wire stiffness is EI, where E is the Young's modulus of the wire material, I is the second moment of area of the wire, and EI is the mathematical product of the two. In a preferred embodiment of the device, the largest EI of wires used in the device is no more than 5 times the smallest EI of wires used in the device. In a more preferred embodiment of the device, the largest EI of wires used in the device is no more than 4 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 2 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 1.5 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 1.3 times the smallest EI of wires used in the device.

Referring again to FIG. 4A, the area of pore 45a adjacent to large wire 42 is much greater than the average area of the five pores 47a, 47b, 47c, 47d, and 47e serially adjacent to pore 45a. For convenience we hereby define the average area of the five pores 47a, 47b, 47c, 47d, and 47e serially adjacent to pore 45a as the mesh pore size. This definition allows us to apply the inventive teachings herein to various filter shapes with varying pore sizes, including tapered filters where the pore size varies along the length of the filter, such as the filter illustrated in FIG. 2. In a preferred embodiment of the mesh at rest in free space, the size of pore 45a adjacent to large wire 42 is no more than 5 times larger than the mesh pore size. In a more preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 4 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 3 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 2 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 1.5 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 1.2 times larger than the mesh pore size.

To achieve the uniform pore size illustrated in FIG. 4B various approaches can be used to match wire stiffnesses. In one embodiment a tubular braided mesh of monofilament 52 (see FIG. 5A) stainless steel wires incorporates an interwoven monofilament wire having a larger diameter than the stainless steel wires with the Young's modulus of the interwoven larger wire less than that of stainless steel. Suitable choices of material for the larger wire include gold and platinum (see Table 1 below). The lower modulus of gold and platinum relative to stainless steel will offset the larger diameter of the radiopaque wire such that the calculated EI's of the radiopaque and non-radiopaque wires will be equal or similar.

TABLE-US-00001 TABLE 1 Material Young's Modulus, E (GPa) Gold 78 Nitinol (Austenitic) 75-83 Platinum 168 Tungsten 411 Tantalum 186 Stainless Steel 199

In an alternate embodiment, multifilament wires 53 can be used (see FIG. 5B). The diameter of each individual filament 54 of a multifilament wire is smaller than the overall diameter of the wire 53 and this allows higher modulus materials to be incorporated into some or all of the filaments 54 of a larger multifilament wire 53. For example, braided tubular mesh comprised of nitinol monofilament wires could incorporate one or more interwoven multifilament wires comprised of gold, platinum, tungsten, tantalum, or other radiopaque materials. In one embodiment of a multifilament wire more than one filament is twisted into a helical shape around a central filament. In another embodiment of multifilament wire 53 individual monofilaments are interwoven into the braid adjacent to each other as shown in FIG. 5E. It is understood that many other combinations of filaments can be devised by one skilled in the art within the scope of the invention.

In a further embodiment, FIGS. 5C and 5D illustrate slotted wire 56 in which monofilament wire 57 has had material removed in the form of slots 58, for example by grinding. Slots 58 have opposing faces 59 and due to material having been removed from the perimeter of the wire to form slots 58 the overall modulus of wire 56 is reduced.

One example of deriving uniform pore size by matching wire stiffnesses is as follows. Tubular braided mesh is comprised of 36 Nitinol monofilament wires of 0.003'' (0.0076 cm) diameter. It is desired to improve the visibility of the mesh by substituting a monofilament circular cross section tungsten wire for one of the nitinol wires, and to do so without significantly changing the pore size of the mesh. The appropriate diameter of the tungsten wire is calculated as shown below. 1/.rho.=M/(E.times.I) Where .rho.=the density of the material in bending, M=the bending moment, and E & I are as defined above. Equating the bending moments of nitinol and tungsten wires yields: (E.sub.w.times.I.sub.w)/.rho..sub.w=M=(E.sub.NiTi.times.I.sub.NiTi).rho..- sub.NiTi and I=(.pi.d.sup.2L.sup.3.rho.)/(48 g) Where .pi.=3.14159, d=monofilament diameter, L=the unsupported transverse length of the filament, and g=the gravitational constant

By combining terms: E.sub.w.times.(.pi.d.sub.w.sup.2L.sub.w.sup.3.rho..sub.w)/(48 g.rho..sub.w)=E.sub.NiTi.times.(.pi.d.sub.NiTi.sup.2L.sub.NiTi.sup.3.rho.- .sub.NiTi)/(48 g.rho..sub.NiTi) and by eliminating like terms: E.sub.w.times.d.sub.w.sup.2=E.sub.NiTi.times.d.sub.NiTi.sup.2

Substituting known values and solving for d.sub.w yields d.sub.w=0.0013''(0.0033 cm)

In another example, the appropriate diameter of gold wire to be substituted into the mesh, using the same calculation as above except substituting into the equations the material parameters of gold in place of the parameters of tungsten, would be d.sub.Au=0.0031'' (0.0079 cm).

In yet another example, the appropriate diameter of nitinol monofilament wires to be braided with 0.0024'' (0.0061 cm) outer diameter 1.times.7 stranded tungsten wire (constructed from a central monofilament of tungsten surrounded by a ring of 6 tungsten monofilaments of the same diameter as the central filament) into tubular braided mesh having uniform pore size is calculated as follows. The equations above are used to calculate EI for each individual tungsten filament (having a filament diameter of 0.0008'' (0.002 cm) in this example). The EI of the stranded wire is approximated as seven times that of one tungsten monofilament (assuming the friction between filaments is small compared to the bending stiffness of the filaments, therefore no adjustment is made for friction). The equations above are solved for d.sub.NiTi by equating EI for the nitinol wire with the calculated EI for the tungsten stranded wire. In this example d.sub.NiTi is approximately equal to 0.0047'' (0.012 cm). It is understood that improved calculations for the stiffness of multifilament wire can be employed as part of these calculations. Improved calculations may account for frictional forces between strands, non-linear configuration of some or all of the strands, or other factors.

Another means for achieving uniform pore size braided mesh comprised of some radiopaque wires is by matching radiopaque and non-radiopaque wire diameters. The smaller the distance between interwoven radiopaque and non-radiopaque wires the greater the variation in pore size caused by differing wire diameters. In a preferred embodiment of the device, the largest diameter of wires used in the device is no more than 5 times the smallest diameter of wires used in the device. In a more preferred embodiment of the device, the largest diameter of wires used in the device is no more than 4 times the smallest diameter of wires used in the device. In a further preferred embodiment of the device, the largest diameter of wires used in the device is no more than 2 times the smallest diameter of wires used in the device. In a further preferred embodiment of the device, the largest diameter of wires used in the device is no more than 1.5 times the smallest diameter of wires used in the device. In a most preferred embodiment both the wire diameter and the wire stiffness of both the radiopaque and non-radiopaque wires are similar.

A method of using a device made from the inventive mesh is as follows. An embolic protection device, made using methods similar to those discussed in connection with FIG. 2, is delivered percutaneously to a region of interest in the body of a patient using methods known in the art. Optionally a catheter is used to deliver the filter to the region of interest. Fluoroscopy is used by the operator to visualize the mouth and the body of the filter to ascertain that the filter is positioned appropriately in relation to a treatment or diagnostic site, for example, positioned such that the mouth of the filter is distal to a stenosis in an artery, and also by example, positioned such that the body of the filter is in a healthy region of vessel suitable for use as a landing zone for the filter. The filter is then deployed and the catheter (if used) is removed from the vicinity of the filter. The operator uses fluoroscopy to ascertain that the mouth of the filter is adequately deployed against the vessel wall with no gaps, distal to the lesion, and proximal to any important side branch vessels. Radiopaque contrast media may be injected at this time or at any time to assist with visualization of the patient's anatomy. The treatment site is treated, for example by dilating a lesion with a balloon dilatation catheter and by deploying a stent or drug eluting stent at the treatment site, although other methods known in the art can be used.

After or during treatment or both, the operator may visualize the mouth and body of the device and may adjust the position of the device to assure, for example, that the device is properly located along the length of the vessel and properly opposed to the vessel wall. After treatment the device is recovered. Optionally a catheter is used during the recovery process. At least a portion of the filter is drawn into the recovery catheter (if used) and the mouth and body of the filter are observed under fluoroscopy to ascertain when the device is sufficiently drawn into the catheter. If difficulty is encountered while drawing the filter into the catheter the devices are again imaged under fluoroscopy and the cause of the difficulty is diagnosed in part by observing the radiopaque portions of the device. The filter (and recovery catheter if used) are then withdrawn from the vessel. If resistance to withdrawal is encountered then the devices are imaged under fluoroscopy and the cause of resistance is determined and eliminated.

While this document has described an invention mainly in relation to braided tubular mesh used for embolic protection filtering devices used in arteries, it is envisioned that the invention can be applied to other conduits in the body as well including veins, bronchi, ducts, ureters, urethra, and other lumens intended for the passage of air, fluids, or solids. The invention can be applied to other devices such as vena cava filters, stents, septal defect closure devices, and other devices comprised of mesh having the benefits described above.

While the various embodiments of the present invention have related to embolic protection filtering devices, the scope of the present invention is not so limited. Further, while choices for materials and configurations have been described above with respect to certain embodiments, one of ordinary skill in the art will understand that the materials described and configurations are applicable across the embodiments.

The above description and the drawings are provided for the purpose of describing embodiments of the invention and are not intended to limit the scope of the invention in any way. It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

* * * * *